Original Research ARTICLE
Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase
- 1Department of Physiology, Federal University of Sergipe, São Cristóvão, Brazil
- 2Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil
- 3Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil
- 4Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil
- 5Department of Biophysics, Federal University of São Paulo, São Paulo, Brazil
B1- and B2-kinin receptors are G protein-coupled receptors that play an important role in the vascular function. Therefore, the present study was designed to evaluate the participation of kinin receptors in the acetylcholine (ACh)-induced vascular relaxation, focusing on the protein-protein interaction involving kinin receptors with endothelial and neuronal nitric oxide synthases (eNOS and nNOS). Vascular reactivity, nitric oxide (NO·) and reactive oxygen species (ROS) generation, co-immunoprecipitation were assessed in thoracic aorta from male wild-type (WT), B1- (B1R−/−), B2- (B2R−/−) knockout mice. Some vascular reactivity experiments were also performed in a double kinin receptors knockout mice (B1B2R−/−). For pharmacological studies, selective B1- and B2-kinin receptors antagonists, NOS inhibitors and superoxide dismutase (SOD) mimetic were used. First, we show that B1- and B2-kinin receptors form heteromers with nNOS and eNOS in thoracic aorta. To investigate the functionality of these protein-protein interactions, we took advantage of pharmacological tools and knockout mice. Importantly, our results show that kinin receptors regulate ACh-induced relaxation via nNOS signaling in thoracic aorta with no changes in NO· donor-induced relaxation. Interestingly, B1B2R−/− presented similar level of vascular dysfunction as found in B1R−/− or B2R−/− mice. In accordance, aortic rings from B1R−/− or B2R−/− mice exhibit decreased NO· bioavailability and increased superoxide generation compared to WT mice, suggesting the involvement of excessive ROS generation in the endothelial dysfunction of B1R−/− and B2R−/− mice. Alongside, we show that impaired endothelial vasorelaxation induced by ACh in B1R−/− or B2R−/− mice was rescued by the SOD mimetic compound. Taken together, our findings show that B1- and B2-kinin receptors regulate the endothelium-dependent vasodilation of ACh through nNOS activity and indicate that molecular disturbance of short-range interaction between B1- and B2-kinin receptors with nNOS might be involved in the oxidative pathogenesis of endothelial dysfunction.
The kallikrein-kinin system (KKS) has multiple functions in the maintenance of cardiovascular system, including vasodilation of peripheral and coronary arteries (Madeddu et al., 1997; Heitsch, 2003), inhibition of endothelin release (Momose et al., 1993), natriuresis and diuresis (Lortie et al., 1992), inhibition of superoxide production (Madeddu et al., 2007), release of nitric oxide (NO·), and synthesis of prostaglandins and endothelium-derived hyperpolarizing factor by endothelial cells (Vanhoutte, 2004; Alhenc-Gelas et al., 2011). Altogether, these studies support the notion that KKS acts as a unique modulator of the cardiovascular system under physiological and pathophysiological conditions (Regoli et al., 2012).
Kallikrein mRNA and protein expression have been identified in blood vessels, which indicate the presence of KKS components in vascular tissue (Saed et al., 1990). KKS biologically active peptides act through two different types of G protein-coupled receptors, B1- and B2-kinin receptors (B1R and B2R), that are expressed at different molecular levels. In the vasculature, both receptors have been implicated in the activation of a wide spectrum of vasoactive pathways (Tsutsui et al., 2000; Felipe et al., 2007; Regoli et al., 2012). Indeed, B2R is ubiquitously expressed whereas B1R is virtually absent in healthy tissues, but its expression is rapidly increased under certain pathological conditions (McLean et al., 2000). However, in spite of the degree of expression, there are compelling evidence supporting that even barely expressed, B1R plays a physiological role and its activation induces vasoconstriction (Felipe et al., 2007) or vasorelaxation (Tsutsui et al., 2000) under unstressed conditions.
It is well-known that the endothelium-dependent vasodilatation in mouse aorta can be primarily attributed to NO· release as the result of endothelial and neuronal nitric oxide synthases (eNOS and nNOS) activity (Pohl et al., 2000; Capettini et al., 2010), which are highly regulated by changes in intracellular Ca2+ concentration, phosphorylation levels and, less known, by protein-protein interactions (Kone et al., 2003). Although previous studies have demonstrated molecular interactions between B2R/eNOS and B2R/nNOS (Ju et al., 1998; Golser et al., 2000), the functionality of such interactions in vascular tissue have not yet been described. Moreover, it has been shown that mice lacking B1- or B2-kinin receptors (B1R−/− or B2R−/−) exhibit impairments in acetylcholine (ACh)-induced vasodilation (Loiola et al., 2011). Therefore, based on the above considerations, the present study was designed to evaluate the participation of kinin receptors in ACh-induced vascular relaxation, focusing on protein-protein interactions involving kinin receptors with eNOS and nNOS.
Materials and Methods
All experimental protocols were performed in accordance with the guidelines for the humane use of laboratory animals and were previously approved by the Animal Ethics Committee of the Federal University of Minas Gerais. Male B1R (B1R−/−), B2R (B2R−/−), double kinin receptors (B1B2R−/−) knockout mice with their wild-type (WT) background controls (C57BL/6J, 10- to 14-wk-old, 25–30 g) were maintained in a temperature-controlled room (22–26°C) on a 12 h light/dark cycle and free access to standard mouse chow and tap water.
Co-immunoprecipitation and Western Blot
Western blots were performed as previously described (Macedo et al., 2016). Thoracic aortas were homogenized in ice-cold lysis buffer (in mM: 150 NaCl, 50 Tris-HCl, 5 EDTA.2 Na and 1 MgCl2, pH 8.0; 1% Triton X-100, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate enriched with a protease inhibitor cocktail; Sigma FAST, Sigma, St. Louis, MO). Homogenates were cleared by centrifugation at 13,000 × g for 15 min at 4°C and protein content was quantified by Lowry assay. To detect protein complexes, proteins of interest were immunoprecipitated by incubating precleared lysates (100–500 μg protein per sample) with anti-B1R (5 μg; goat polyclonal, #sc-15048), anti-B2R (5 μg; rabbit polyclonal, #sc-25671), anti-eNOS (1 μg; rabbit polyclonal, #sc-654), or anti-eNOS (1 μg; rabbit polyclonal, #sc-8309) antibodies (all from Santa Cruz Biotechnology, USA). For kinin receptors immunoprecipitation, sample-antibody (500 μg:5 μg ratio) binding complex was carried out overnight at 4°C with constant end-over-end mixing, followed by incubation with 50 μL of Protein G Magnetic Beads (Dynabeads®, Invitrogen, #10003D) for 3 h at 4°C. For NOS immunoprecipitation, sample-antibody (100 μg:1 μg ratio) binding complex was carried out for 2 h at 4°C, followed by incubation with 10 μL of protein A/G-Sepharose beads (ThermoScientific, Waltham, USA, #53132) at 4°C overnight. As IgG control, protein extracts (500 μg) were also immunoprecipitated with normal rabbit serum (Santa Cruz Biotechnology, USA, #sc-2027) in order to assess the specificity of our antibodies. Afterwards, beads were washed 3x with lysis buffer and pelleted to remove unbound proteins. Precipitated proteins were eluted from the beads by boiling in Laemmli buffer, resolved using 10% gel electrophoresis (SDS-PAGE) and transferred onto a nitrocellulose membrane (Merck-Millipore, USA). For WB, membranes were incubated with anti-eNOS (1:1000, mouse monoclonal, #N38620, Transduction Laboratories), anti-nNOS (1:1000, mouse monoclonal, #N31020, Transduction Laboratories), anti-B1R (1:1000, #sc-15048, Santa Cruz Biotechnology, USA) and anti-B2R (1:1000, #sc-25671, Santa Cruz Biotechnology, USA) at 4°C overnight, followed by appropriate horseradish peroxidase-conjugated secondary antibodies (dilution 1:10000; Sigma, USA). Immunodetection was performed using enhanced chemiluminescence (Luminata strong™—Western HRP substrate, Merck-Millipore, USA) and images acquired using radiographic film or ChemiDoc XRS system (BioRad, USA).
Rings from the thoracic aorta were obtained and processed as previously described (Capettini et al., 2008). Vessels were transferred to an organ bath containing Krebs-Henseleit (K-H) solution (in mM: 110.8 NaCl, 5.9 KCl, 25.0 NaHCO3, 1.07 MgSO4, 2.49 CaCl2, 2.33 NaH2PO4, and 11.51 glucose, pH 7.4) maintained at 37°C and then, resting tension was adjusted stepwise to reach 0.5 g and allowed to stabilize for 1 h. ACh or substance P was added in increasing cumulative concentrations once the response to phenylephrine (0.1 μM) had stabilized. Preparations were then incubated for 20 min in the presence or absence of a B1R-selective antagonist (Des-Arg10 HOE 140; 1 μM), or a B2R-selective antagonist (HOE 140; 1 μM; Wirth et al., 1992; Regoli et al., 1998), a non-selective NOS isoforms inhibitor (NG-nitro-L-arginine, L-NNA; 1 μM; Pérez et al., 2009), a selective nNOS inhibitor [1-(2-trifluoromethylphehyl) imidazole, TRIM; 100 μM; Handy and Moore, 1997] or a superoxide dismutase (SOD) mimetic (Mn (III) tetrakis [1-methyl-4-pyridyl] porphyrin, MnTMPyP; 10 μM; Fontana et al., 1999). After pre-incubation period, a second cumulative concentration-response curve for ACh was constructed. For endothelium-independent vasorelaxation, the endothelium was removed by gently rubbing the lumen of the aortic rings. The absence of endothelium was confirmed by the lack of relaxant response to ACh in aortic rings pre-contracted with phenylephrine. Subsequently, concentration–response curve for sodium nitroprusside (SNP) was constructed. Mechanical activity was recorded isometrically using a force transducer (World Precision Instruments, Inc., Sarasota, FL, USA) connected to an amplifier-recorder (TBM-4 model; Word Precision Instruments, Inc., Sarasota, FL, USA) and a personal computer equipped with an analog-digital converter board (AD16JR; Word Precision Instruments, Inc., Sarasota, FL, USA), using WinDaq Data Acquisition software (Dataq® Instruments, USA).
Measurements of NO· Production and Superoxide Generation
NO· production in the aorta was determined using a fluorescent cell-permeable dye, 4,-amino-5 methylamino-2′,7′-diaminofluorescein diacetate (DAF-FM, 10 μM; Molecular Probes) as previously described (Mota et al., 2015). Intracellular superoxide levels were assessed using dihydroethidium (DHE, 10 μM; Calbiochem). Freshly isolated aortas were incubated with dyes and loaded for 30 min at 37°C in K-H solution and then washed for 30 min. Thoracic aorta segments were frozen and cut into sections that were 10 μm thick. For some experiments, fresh aortic rings from WT mice were incubated in the presence or absence of Des-Arg10 HOE 140, HOE 140 (1 μM) or MnTMPyP (10 μM) for 30 min prior to ACh stimulation (10 μM, 30 min). Images were recorded using a fluorescence microscope (IX2-ICB, Olympus®, USA), and image analyses were performed in ImageJ software (NIH).
All data are expressed as mean ± SEM. Vascular responses are expressed as % relaxation of the tone induced by phenylephrine. Significant differences between groups were determined using Two-way ANOVA followed by Bonferroni's post-hoc tests to compare the concentration-response curves obtained in aortic rings. Fluorescence microscopy images were analyzed according to the intensity of the fluorescence per area, both represented in arbitrary units (a.u.). The delta of the area under the curve was calculated as the difference between the concentration-response curves in the presence and the absence of MnTMPyP. One-way ANOVA followed by Bonferroni's post-hoc tests were used for all other analyses. All statistical comparisons were made using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA) and values of P < 0.05 were considered to be statistically significant.
Protein-Protein Interactions between Constitutive NOS Isoforms and Kinin Receptors
In order to identify the existence of protein-protein interactions involving kinin receptors and constitutive NOS in native vascular tissue, thoracic aortas from WT mice were lysed and proteins were immunoprecipitated with anti-B1R, anti-B2R, anti-eNOS, and anti-nNOS antibodies. As shown in Figures 1A,B, the positive control, non-precipitated aortic lysate (input), show a strong signal at proper molecular weight, whereas IgG signal was barely detected (Figure 1A) or absent (Figure 1B) in samples immunoprecipitated with normal rabbit serum. Moreover, we show that eNOS (Figure 1A) and nNOS (Figure 1B) physically interact with B1- and B2-kinin receptors. We further validate our findings by performing opposite protein immunoprecipitation experiments (Figures 1C,D).
Figure 1. Protein-protein interactions between constitutive NOS and kinin receptors. Thoracic aorta proteins of wild type mice were used for immunoprecipitation experiments (IP). (A,B) Non-precipitated aortic lysates was used as a positive control (input, 50 μg of protein), whereas immunoprecipitation with normal rabbit serum was used as an IgG control. Proteins were immunoprecipitated using anti-B1R or anti-B2R antibody followed by WB with anti-eNOS (A) or anti-nNOS (B). (C,D) Proteins were immunoprecipitated using anti-eNOS or anti-nNOS antibody followed by WB with anti-B1R (C) or anti-B2R (D). Data shown are representative of four separate experiments, each of which provided nearly identical results.
Based on our findings that both B1- and B2-kinin receptors are expressed and physically interact with nNOS and eNOS, we next sought to investigate the functionality of these interactions. To address this question, we evaluated whether kinin receptors are involved in the endothelial vasodilator response to ACh, in which leads to vasorelaxation via NOS activation. As shown in the Figure 2, aortic rings exhibited concentration-dependent vasodilation in response to ACh, which was partially reduced by pre-incubation with the selective inhibitor of nNOS (TRIM; Figures 2A,C) and markedly decreased by the non-selective NOS inhibitor (L-NNA; Figures 2B,D). To assess the contribution of B1- and B2-kinin receptors in the endothelium-dependent vasodilation response elicited by ACh, aortas were pre-incubated with either a selective B1R or B2R antagonist. Interestingly, blockage of B1R (Figures 2A,B) or B2R (Figures 2C, D) led to a significant reduction in ACh-induced vasorelaxation.
Figure 2. Pharmacologic antagonism of B1- or B2-kinin receptors attenuates ACh-induced vasodilation. Cumulative concentration-response curves for ACh were determined using an antagonist of the B1-kinin receptor (A,B; Des-Arg10 HOE 140; 1 μM) or B2-kinin receptor (C,D; HOE 140; 1 μM) in combination with a selective inhibitor of nNOS (A,C; TRIM; 100 μM) or constitutive NOS (B,D; L-NNA; 1 μM). The results are expressed as mean ± SEM for 8–10 experiments in each group. ***P < 0.001.
To better understand the individual contribution of eNOS and nNOS in the reduced vasorelaxation response to ACh upon B1- and B2-kinin receptor blockage, we performed experiments combining kinin receptor antagonists and NOS inhibitors. Our results show that pre-incubation with Des-Arg10 HOE 140 in combination with L-NNA (Figure 2B) or HOE 140 plus L-NNA (Figure 2D) fully abolished the vasorelaxation induced by ACh. However, pre-incubation with TRIM in combination with kinin receptors antagonists did not potentiate the inhibitory effect of Des-Arg10 HOE 140 (Figure 2A) or HOE 140 (Figure 2C) on vasodilator responses.
To assess whether B1- and B2-kinin receptors affect endothelium-independent vasorelaxation, the NO· donor SNP was used to induce relaxation in endothelium-denuded aortic rings. As shown in the Figure 3, pre-incubation of B1- and B2-kinin receptors antagonists did not change the SNP-induced relaxation. As expected, non-selective NOS inhibition did not affect the endothelium-independent relaxation induced by the NO· donor. Collectively, these findings suggest that blockade of kinin receptors affects ACh-induced vascular relaxation via impairment of nNOS activation.
Figure 3. Endothelium-independent vascular relaxation mediated by NO· donor (sodium nitroprusside, SNP) was not modified in aortic rings treated with B1- and B2- kinin receptor antagonists. Cumulative concentration-response curves for SNP were determined using an antagonist of the B1-kinin receptor (Des-Arg10 HOE 140; 1 μM), B2-kinin receptor (HOE 140; 1 μM) or NOS inhibitor (L-NNA; 1 μM). The results are expressed as mean ± SEM for 4–6 experiments in each group.
Genetic Deletion of B1- or B2-Kinin Receptors Impairs ACh-Induced Vasorelaxation
To unequivocally demonstrate that kinin receptors contribute to the endothelium-dependent vasodilation elicited by ACh, we made use of knock-out mice that lack either B1- or B2-kinin receptors. As shown in Figure 4A, impaired ACh-induced vasorelaxation was found in B1R−/− and B2R−/− mice compared with WT. Furthermore, substance P, another endothelium-dependent vasodilator via NOS activation, induced a concentration-dependent vasodilation in WT mice, which was significantly decreased in B1R−/− and B2R−/− (Figure 4B). Consistent with pharmacological approach, the selective inhibition of nNOS did not potentiate the impaired ACh-induced vasodilation in B1R−/− or B2R−/− mice whereas pre-incubation with L-NNA fully abolished the residual ACh-induced vasodilation (Figures 4C,D). Moreover, impaired ACh-induced vasorelaxation was not amplified in B1B2R−/− (Emax: 52.1 ± 6.5%, Figure 5) when compared with B1R−/− or B2R−/− (Table 1). Overall, these data validate our findings with pharmacological approach and indicate that uncoupled nNOS activity is the main cause of endothelial dysfunction in aorta of B1R−/− and B2R−/− mice.
Figure 4. Genetic deletion of B1- or B2-kinin receptors impairs ACh-and Substance P-induced vasodilation. Cumulative concentration-response curves for Ach (A) and substance P (B) in B1R−/− and B2R−/− mice. Further ACh-induced vasodilation was determined in the presence and absence of selective inhibitors of nNOS (C,D; TRIM; 100 μM) or constitutive NOS (C,D; L-NNA; 1 μM). The results are expressed as mean ± SEM for 8–10 experiments in each group. ***P < 0.001.
Figure 5. Genetic deletion of B1- and B2-kinin receptors (B1B2R−/−) does not amplify the impairment of ACh-induced vasodilation. Cumulative concentration-response curves for ACh in WT (n = 15) and B1B2R−/− (n = 11) mice. ***P < 0.001.
Contribution of B1- or B2-Kinin Receptors on NO· Production and Superoxide Generation
Taking into account that oxidative stress is a major contributor and marker of endothelial dysfunction, we next investigated the superoxide generation in thoracic aortic rings. As shown in the Figure 6A, ACh was able to raise superoxide levels, in which were fully restored by the SOD-like membrane permeable compound, MnTMPyP, a superoxide scavenger. In line with reduced vasodilation, acute pharmacological blockage of B1- or B2-kinin receptors markedly potentiates DHE fluorescence when compared to ACh-stimulated aortic rings in the absence of kinin receptors antagonists (Figure 6A). Moreover, we also show that NO· levels were significantly decreased in rings from B1R−/− and B2R−/− mice compared to WT (Figure 6B). Accordingly, B1R−/− and B2R−/− aortas exhibited an increased superoxide levels when compared to WT (Figure 6C). Altogether, our data show that reduced NO· bioavailability and greater ROS generation are linked with the impaired endothelium-dependent vasorelaxation of B1R−/− and B2R−/− mice.
Figure 6. Contribution of B1 - or B2-kinin receptors on NO production and ROS generation. (A) DHE fluorescence in aortic rings from WT mice incubated in presence or absence of Des-Arg10 HOE 140, HOE 140 (1 μM) or MnTMPyP (10 μM) for 30 min prior to ACh stimulation (10 μM, 30 min). (B,C, Top) Representative images of aortic rings from WT, B1R−/− and B2R−/− mice loaded with NO· indicator (B) and superoxide indicator (C). (B,C, Bottom) Quantitative analysis of DAF (B) and DHE fluorescence (C). n = 15–20 aortic rings analyzed from 3 animals. Scale bar = 20 μm. The results are expressed as mean ± SEM. *P < 0.05; ***P < 0.001 vs. WT.
SOD Mimetic MnTMPyP Rescues Impaired Endothelium-Dependent Vasorelaxation in Mice Lacking B1- or B2-Kinin Receptors
In order to confirm whether oxidative stress is involved in the endothelial dysfunction of B1R−/− and B2R−/− mice, ACh-induced vasorelaxation curves were performed in the presence of MnTMPyP. As shown in the Figures 7A,B, ACh-induced vasorelaxation was leftward shifted in MnTMPyP-treated aortic rings when compared to non-treated vessels of WT mice. Interestingly, in aortic rings from B1R−/− and B2R−/− mice, MnTMPyP restored the ACh-induced vasorelaxation (Figures 7A,B). The difference of the area under curve shows that the SOD mimetic enhanced ACh-induced vasorelaxation in all tested groups; however, B1R−/− and B2R−/− mice reached a significant enhancement when compared to WT mice (Figure 7C). Taken together, these data support the oxidative pathogenesis hypothesis of the endothelial dysfunction found in B1R−/− and B2R−/− mice.
Figure 7. Superoxide dismutase mimetic (MnTMPyP) rescues impaired ACh-induced vasodilation in mice lacking B1- or B2-kinin receptors. Cumulative concentration-response curves for ACh in B1R−/− (A) and B2R−/− mice (B) in the presence and absence of MnTMPyP (10 μM). Delta of the area under the curve representing the enhancement MntMPyP effect on the vasodilation of ACh in WT, B1R−/− and B2R−/−mice (C). The results are expressed as mean ± SEM for 5–10 experiments in each group. **P < 0.01 and ***P < 0.001 vs. WT.
The main findings of this study are as follows: (1) both B1- and B2-kinin receptors form heteromers with nNOS and eNOS in thoracic aorta; (2) B1- and B2-kinin receptors equally play an important role in the regulation of endothelium-dependent vasodilation of ACh through nNOS activity; (3) the oxidative stress is closely related with the onset of endothelial dysfunction in aorta of B1R−/− and B2R−/− mice.
Kinin receptors have been reported to play a pivotal role in numerous vascular responses (Berthiaume et al., 1997; Felipe et al., 2007). Although it remains controversial whether B1R−/− and B2R−/− mice are normotensive (Milia et al., 2001; Trabold et al., 2002; Abadir et al., 2003) or hypertensive (Madeddu et al., 1997, 1998; Emanueli et al., 1998, 1999), these mice exhibit increased susceptibility to develop hypertension in response to different stressor stimuli (Alfie et al., 1997; Madeddu et al., 1997; Duka et al., 2001). Furthermore, it was previously demonstrated that mice lacking B1- or B2-kinin receptors display a decreased NO· bioavailability, despite the increased enzymatic activity of the constitutive NOS isoform (Loiola et al., 2011). Thus, these findings indicate that the vascular NOS activity might be uncoupled in B1R−/− and B2R−/− mice. Moreover, whether ROS generation is involved, or not, in this vascular dysfunction remains unknown. Besides of these important issues, identification of the uncoupled NOS isoform represents another relevant question that could explain the underlying mechanisms and molecular basis of NOS uncoupling in B1R−/− and B2R−/− mice.
Ca2+-dependent NOS, which include eNOS and nNOS, are tightly regulated by several regulatory sites. Furthermore, new molecular regulators have been identified affecting their activities and, consequently, the amount of critical end-products for vascular function. Notably, protein-protein interactions have been proposed as an important mechanism that regulates the activity of NOS (Kone et al., 2003). Indeed, several studies have already described the functional relevance of physical interactions between NOS with a wide variety of structural and regulatory proteins such as, calmodulin (Rizzo et al., 1998), caveolin-1 (Ghosh et al., 1998), heat shock protein 90 (Russell et al., 2000), α1A adrenergic receptors (Pupo and Minneman, 2002), and angiotensin II receptor type 1 (AbdAlla et al., 2000). Although the heteromerization of B2-kinin receptor with nNOS and eNOS was previously reported (Ju et al., 1998; Golser et al., 2000), this study is the first to demonstrate B1R–eNOS/nNOS heteromerization. Moreover, although we are the first group to actually demonstrate such macromolecular protein complexes in native vascular tissue, if these interactions are functionally coupled to each other and, more importantly, whether this affects vascular function, it has remained unknown until now.
Here, we showed that eNOS and nNOS inhibition strongly decreases the ACh-induced vasorelaxation, confirming the large contribution of both constitutive NOS as the main source of NO· production. Intriguingly, pharmacologic antagonism or genetic ablation of B1- or B2-kinin receptors decreased the endothelium-dependent vasorelaxation response to ACh. Therefore, our results show that kinin receptors act as regulators of NOS activity in endothelial cells. To identify whether kinin receptors differently modulate eNOS and nNOS activities, the vasorelaxation response to ACh was assessed combining kinin receptors antagonists and NOS inhibitors. Our results demonstrated that B1- and B2-kinin receptors blockage fully abolished the relaxation upon non-selective NOS inhibition whereas nNOS inhibition did not potentiate the reduction of vasorelaxation induced by kinin receptors antagonism. In addition, we found similar pattern of vascular response in aorta from B1R−/− and B2R−/− mice. It is worth noting that non-selective NOS inhibition and B1- or B2-kinin receptors antagonists led to vascular contraction. These vascular responses further support that inhibition of the main vasodilation pathway favors contractile mechanisms, in which the oxidative stress is well-known to play a dysfunctional role in several vascular disorders (Johansson et al., 2005; Loria et al., 2014). Moreover, a reasonable explanation for selecting ACh as the agonist to trigger the vasorelaxation in the present study is the well-known NOS activation by muscarinic pathway whereas, the vascular response of agonists of kinin receptors is still controversial in aorta of different species, where it produces vasoconstriction (Levesque et al., 1993; Felipe et al., 2007) or vasodilation (Tsutsui et al., 2000). Furthermore, previous evidence has already demonstrated the absence of protein-protein interactions between kinin and muscarinic receptors (Willars et al., 1999). Importantly, we also validated the vascular dysfunction in B1R−/− and B2R−/− mice assessing the vasodilation induced by another well-known NOS activator, substance P. Taken together, our results show that B1- and B2-kinin receptors represent a functional regulatory domain of NOS activity. Moreover, our findings indicate that eNOS activity remained unaffected whereas the loss of nNOS function may represent a potential uncoupled activity.
Taking into account that B1R and B2R receptors are expressed in endothelial and smooth muscle layers (Leeb-Lundberg et al., 2005), kinin receptors may also affect the vascular relaxation by changing the responsiveness to NO· or, by acting on other targets resident in the vascular smooth muscle. To test this hypothesis, the vasodilator response to an exogenous NO· donor was used. Our results showed that kinin receptors did not affect the vasodilator response to NO· donor, which indicate a preserved smooth muscle function. Therefore, our findings strongly indicate that the endothelial dysfunction is the main cause of impaired vascular relaxation in aorta of B1R−/− and B2R−/− mice. Importantly, a cross-talk between B1R and B2R has been reported (Barki-Harrington et al., 2003), indicating an interdependence with each other for the proliferative response. Moreover, it has been also shown that B1B2R−/− mice display protection against endotoxin-induced hypotension (Cayla et al., 2007) and obesity induced by high fat diet (Morais et al., 2015), while there are evidence showing amplified renal injury after ischemia/reperfusion (Kakoki et al., 2007) and increased nephropathy, neuropathy and bone mineral loss in Akita diabetic mice (Kakoki et al., 2010). Thus, in the present study we show that B1B2R−/− mice present similar level of vascular dysfunction as found in mice lacking B1R or B2R, and therefore ruling out a possible synergistic response between these receptors in this mechanism. Although still under debate whether endothelial dysfunction is a primary cause or consequence of vascular diseases, such vascular dysfunction is generally associated with decreased NO· bioavailability and increased superoxide generation which ultimately lead to an impaired endothelium-dependent vasorelaxation (Vanhoutte et al., 2017).
Under physiological conditions, the activity of eNOS is able to produce NO·, whereas nNOS activity produces NO· and hydrogen peroxide (H2O2; Rosen et al., 2002; Gao et al., 2007). However, during certain pathological stimuli, the activity of eNOS and nNOS is drastically modified and becomes primarily uncoupled, producing a large amount of ROS, mainly, superoxide (Vasquez-Vivar et al., 1998; Weaver et al., 2005). Consistent with impaired vasodilation, acute blockage of kinin receptors markedly potentiate ACh-induced superoxide generation in aorta of WT mice. Additionally, we also demonstrated that B1R−/− and B2R−/− mice show a reduced NO· bioavailability associated with marked increase in intracellular levels of superoxide. Therefore, although the enhanced constitutive NOS activity in vascular tissue of B1R−/− and B2R−/− mice, our findings indicate that the uncoupled activity of nNOS represents a remarkable source of superoxide and, may be the major cause of the endothelial dysfunction in B1R−/− and B2R−/− mice.
Indeed, the oxidative stress is the major cause of endothelial dysfunction in several forms of vascular diseases, mainly via disruption of NO· signaling pathway (Drummond et al., 2011; Silva et al., 2016). Therefore, enhanced superoxide anion dismutation through the SOD mimetic can prevents the inactivation of NO· and formation of the highly reactive intermediate peroxynitrite (Weaver et al., 2005), and thus yielding augmented H2O2 concentration, an endothelium-dependent relaxing factor in aorta (Capettini et al., 2008, 2010). Accordingly, the left-shifted ACh-induced vasodilation in WT may be explained by the above factors. Moreover, the stronger enhancement of vascular relaxation induced by the SOD mimetic in B1R−/− and B2R−/− mice than in WT mice further support our hypothesis of oxidative stress involvement in the endothelial dysfunction. These findings are consistent with previous studies, in which the exogenous SOD mimetic restores endothelium-dependent vasodilation due increased NO· bioavailability (Fontana et al., 1999; Braga et al., 2015).
nNOS uncoupling has been implicated in several endothelium-dependent vascular disorders such as, in mesenteric artery of DOCA-salt hypertensive mice (Silva et al., 2016), thoracic aorta subjected to experimental atherosclerosis model (Capettini et al., 2011) and penile arteries of obese Zucker rat (Sánchez et al., 2012). Accordingly, deficient mice of B1-kinin receptor has been described to aggravate atherosclerosis and the development of abdominal aorta aneurysms in ApoE−/− mice under cholesterol rich-diet (Merino et al., 2009). B2-kinin receptor deficient mice also demonstrate higher blood pressure in response to chronic excess of angiotensin II or dietary salt (Madeddu et al., 1997) and chronic mineralocorticoid excess (Emanueli et al., 1998). Moreover, pharmacologic blockade or genetic disruption of the B2-kinin receptor accelerates the development of renovascular hypertension induced by clipping of the left renal artery (Madeddu et al., 1998). On the other hand, a recently study demonstrated that B2-kinin receptor antagonist inhibited AngII-induced neutrophil activation and inflammatory phenotype in ApoE−/− mice, thus suggesting B2-kinin receptor antagonism as potential therapy for abdominal aortic aneurysm (Moran et al., 2016). Therefore, further studies are necessary in disease models to test the hypothesis whether the conformational rearrangement of protein-protein interactions, involving kinin receptors and NOS isoforms, is relevant to vascular dysfunction.
In summary, we provide data supporting a novel implication of kinin receptors in the endothelial dysfunction. We report here that B1- and B2-kinin receptors regulate the endothelium-dependent vasodilation of ACh through nNOS activity and indicate that molecular disturbance of short-range interactions between B1- and B2-kinin receptors with nNOS is involved in the oxidative pathogenesis of endothelial dysfunction.
TM participated in all steps of this study. GC and IJ performed experiments. SL, LC, VL, JC, EC, JLP, and JBP contributed to the experimental design, data analyses, data interpretation, and the preparation and revision of the manuscript.
This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil), PROMOB–Coordenação de Aperfeiçoamento de Pessoal de Nível Superior e Fundação de Apoio à Equipe e à Inovação Tecnológica do Estado de Sergipe (CAPES/FAPITEC/SE, Brazil), Fundação de Amparo à Pesquisa do estado de Minas Gerais (FAPEMIG/MG, Brazil). JC and EC are CNPq research fellow.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abadir, P. M., Carey, R. M., and Siragy, H. M. (2003). Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor–null mice. Hypertension 42, 600–604. doi: 10.1161/01.HYP.0000090323.58122.5C
Alfie, M. E., Sigmon, D. H., Pomposiello, S. I., and Carretero, O. A. (1997). Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 29, 483–487. doi: 10.1161/01.HYP.29.1.483
Alhenc-Gelas, F., Bouby, N., Richer, C., Potier, L., Roussel, R., and Marre, M. (2011). Kinins as therapeutic agents in cardiovascular and renal diseases. Curr. Pharm. Des. 17, 2654–2662. doi: 10.2174/138161211797416002
Barki-Harrington, L., Bookout, A. L., Wang, G., Lamb, M. E., Leeb-Lundberg, L. M. F., and Daaka, Y. (2003). Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem. J. 371, 581–587. doi: 10.1042/bj20021708
Berthiaume, N., Hess, F., Chen, H., Regoli, D., and D'Orléans-Juste, P. (1997). Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur. J. Pharmacol. 333, 55–61. doi: 10.1016/S0014-2999(97)01096-0
Braga, V. A. V. N., Couto, G. K., Lazzarin, M. C., Rossoni, L. V., and Medeiros, A. (2015). Aerobic exercise training prevents the onset of endothelial dysfunction via increased nitric oxide bioavailability and reduced reactive oxygen species in an experimental model of menopause. PLoS ONE 10:e0125388. doi: 10.1371/journal.pone.0125388
Capettini, L., Cortes, S., Silva, J., Alvarez-Leite, J., and Lemos, V. (2011). Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. Br. J. Pharmacol. 164, 1738–1748. doi: 10.1111/j.1476-5381.2011.01500.x
Capettini, L. S. A., Cortes, S. F., Gomes, M. A., Silva, G., A., B., Pesquero, J. L., Lopes, M. J., et al. (2008). Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor. Am. J. Physiol. Heart Circ. Physiol. 295, H2503–H2511. doi: 10.1152/ajpheart.00731.2008
Capettini, L. S. A., Cortes, S. F., and Lemos, V. S. (2010). Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouse aorta. Eur. J. Pharmacol. 643, 260–266. doi: 10.1016/j.ejphar.2010.06.066
Cayla, C., Todiras, M., Iliescu, R., Saul, V. V., Gross, V., Pilz, B., et al. (2007). Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 21, 1689–1698. doi: 10.1096/fj.06-7175com
Drummond, G. R., Selemidis, S., Griendling, K. K., and Sobey, C. G. (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453–471. doi: 10.1038/nrd3403
Duka, I., Kintsurashvili, E., Gavras, I., Johns, C., Bresnahan, M., and Gavras, H. (2001). Vasoactive Potential of the B1 bradykinin receptor in normotension and hypertension. Circ. Res. 88, 275–281. doi: 10.1161/01.RES.88.3.275
Emanueli, C., Fink, E., Milia, A. F., Salis, M. B., Conti, M., Demontis, M. P., et al. (1998). Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene. Hypertension 31, 1278–1283. doi: 10.1161/01.HYP.31.6.1278
Emanueli, C., Maestri, R., Corradi, D., Marchione, R., Minasi, A., Tozzi, M. G., et al. (1999). Dilated and failing cardiomyopathy in bradykinin B2 receptor knockout mice. Circulation 100, 2359–2365. doi: 10.1161/01.CIR.100.23.2359
Felipe, S. A., Rodrigues, E. S., Martin, R. P., Paiva, A. C. M., Pesquero, J. B., and Shimuta, S. I. (2007). Functional expression of kinin B1 and B2 receptors in mouse abdominal aorta. Braz. J. Med. Biol. Res. 40, 649–655. doi: 10.1590/S0100-879X2007000500007
Fontana, L., McNeill, K. L., Ritter, J. M., and Chowienczyk, P. J. (1999). Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br. J. Pharmacol. 126, 730–734. doi: 10.1038/sj.bjp.0702331
Gao, Y. T., Roman, L. J., Martásek, P., Panda, S. P., Ishimura, Y., and Masters, B. S. S. (2007). Oxygen metabolism by endothelial nitric-oxide synthase. J. Biol. Chem. 282, 28557–28565. doi: 10.1074/jbc.M704890200
Ghosh, S., Gachhui, R., Crooks, C., Wu, C., Lisanti, M. P., and Stuehr, D. J. (1998). Interaction between Caveolin-1 and the reductase domain of endothelial nitric-oxide synthase consequences for catalysis. J. Biol. Chem. 273, 22267–22271. doi: 10.1074/jbc.273.35.22267
Golser, R., Gorren, A. C. F., Leber, A., Andrew, P., Habisch, H.-J., Werner, E. R., et al. (2000). Interaction of endothelial and neuronal nitric-oxide synthases with the bradykinin B2 receptor binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. J. Biol. Chem. 275, 5291–5296. doi: 10.1074/jbc.275.8.5291
Handy, R. L. C., and Moore, P. K. (1997). Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM). Life Sci. 60, PL389–PL394. doi: 10.1016/S0024-3205(97)00295-6
Johansson, M. E., Hägg, U., Wikström, J., Wickman, A., Bergström, G., and Gan, L. (2005). Haemodynamically significant plaque formation and regional endothelial dysfunction in cholesterol-fed ApoE−/− mice. Clin. Sci. 108, 531–538. doi: 10.1042/CS20040322
Ju, H., Venema, V. J., Marrero, M. B., and Venema, R. C. (1998). Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J. Biol. Chem. 273, 24025–24029. doi: 10.1074/jbc.273.37.24025
Kakoki, M., McGarrah, R. W., Kim, H.-S., and Smithies, O. (2007). Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 104, 7576–7581. doi: 10.1073/pnas.0701617104
Kakoki, M., Sullivan, K. A., Backus, C., Hayes, J. M., Oh, S. S., Hua, K., et al. (2010). Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc. Natl. Acad. Sci. U.S. A. 107, 10190–10195. doi: 10.1073/pnas.1005144107
Kone, B. C., Kuncewicz, T., Zhang, W., and Yu, Z.-Y. (2003). Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Ren. Physiol. 285, F178–F190. doi: 10.1152/ajprenal.00048.2003
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005). International union of pharmacology. XLV. classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27–77. doi: 10.1124/pr.57.1.2
Levesque, L., Drapeau, G., Grose, J. H., Rioux, F., and Marceau, F. (1993). Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Br. J. Pharmacol. 109, 1254–1262. doi: 10.1111/j.1476-5381.1993.tb13757.x
Loiola, R. A., Reis, F. C. G., Kawamoto, E. M., Scavone, C., Abdalla, D. S., Fernandes, L., et al. (2011). Role of vascular Kinin B1 and B2 receptors in endothelial nitric oxide metabolism. Peptides 32, 1700–1705. doi: 10.1016/j.peptides.2011.06.010
Loria, A. S., Brinson, K. N., Fox, B. M., and Sullivan, J. C. (2014). Sex-specific alterations in NOS regulation of vascular function in aorta and mesenteric arteries from spontaneously hypertensive rats compared to Wistar Kyoto rats. Physiol. Rep. 2:e12125. doi: 10.14814/phy2.12125
Lortie, M., Regoli, D., Rhaleb, N. E., and Plante, G. E. (1992). The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 262, R72–R76.
Macedo, F. N., Mesquita, T. R. R., Melo, V. U., Mota, M. M., Silva, T. L. T. B., Santana, M. N., et al. (2016). Increased nitric oxide bioavailability and decreased sympathetic modulation are involved in vascular adjustments induced by low-intensity resistance training. Front. Physiol. 7:265. doi: 10.3389/fphys.2016.00265
Madeddu, P., Emanueli, C., and El-Dahr, S. (2007). Mechanisms of Disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling. Nat. Rev. Nephrol. 3, 208–221. doi: 10.1038/ncpneph0444
Madeddu, P., Milia, A. F., Salis, M. B., Gaspa, L., Gross, W., Lippoldt, A., et al. (1998). Renovascular Hypertension in Bradykinin B2-Receptor Knockout Mice. Hypertension 32, 503–509. doi: 10.1161/01.HYP.32.3.503
Madeddu, P., Varoni, M. V., Palomba, D., Emanueli, C., Demontis, M. P., Glorioso, N., et al. (1997). Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96, 3570–3578. doi: 10.1161/01.CIR.96.10.3570
McLean, P. G., Perretti, M., and Ahluwalia, A. (2000). Kinin B1 receptors and the cardiovascular system: regulation of expression and function. Cardiovasc. Res. 48, 194–210. doi: 10.1016/S0008-6363(00)00184-X
Merino, V. F., Todiras, M., Mori, M. A., Sales, V. M. T., Fonseca, R. G., Saul, V., et al. (2009). Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J. Mol. Med. 87, 953–963. doi: 10.1007/s00109-009-0501-0
Milia, A. F., Gross, V., Plehm, R., Silva, J. A. D., Bader, M., and Luft, F. C. (2001). Normal blood pressure and renal function in mice lacking the bradykinin B2 receptor. Hypertension 37, 1473–1479. doi: 10.1161/01.HYP.37.6.1473
Momose, N., Fukuo, K., Morimoto, S., and Ogihara, T. (1993). Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension 21, 921–924. doi: 10.1161/01.HYP.21.6.921
Morais, R. L., Silva, E. D., Sales, V. M., Filippelli-Silva, R., Mori, M. A., Bader, M., et al. (2015). Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice. Diabetes Metab. Syndr. Obes. Targets Ther. 8, 399–407. doi: 10.2147/DMSO.S87635
Moran, C. S., Rush, C. M., Dougan, T., Jose, R. J., Biros, E., Norman, P. E., et al. (2016). Modulation of Kinin B2 receptor signaling controls aortic dilatation and rupture in the angiotensin II–infused apolipoprotein E–deficient mousesignificance. Arterioscler. Thromb. Vasc. Biol. 36, 898–907. doi: 10.1161/ATVBAHA.115.306945
Mota, M. M., Mesquita, T. R. R., Braga da Silva, T. L. T., Fontes, M. T., Lauton Santos, S., dos Santos Aggum Capettini, L., et al. (2015). Endothelium adjustments to acute resistance exercise are intensity-dependent in healthy animals. Life Sci. 142, 86–91. doi: 10.1016/j.lfs.2015.10.007
Pérez, F. R., Venegas, F., González, M., Andrés, S., Vallejos, C., Riquelme, G., et al. (2009). Endothelial epithelial sodium channel inhibition activates endothelial nitric oxide synthase via phosphoinositide 3-kinase/akt in small-diameter mesenteric arteries. Hypertension 53, 1000–1007. doi: 10.1161/HYPERTENSIONAHA.108.128520
Pohl, U., De Wit, C., and Gloe, T. (2000). Large arterioles in the control of blood flow: role of endothelium-dependent dilation. Acta Physiol. Scand. 168, 505–510. doi: 10.1046/j.1365-201x.2000.00702.x
Pupo, A. S., and Minneman, K. P. (2002). Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol. 2:17. doi: 10.1186/1471-2210-2-17
Rizzo, V., McIntosh, D. P., Oh, P., and Schnitzer, J. E. (1998). In Situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J. Biol. Chem. 273, 34724–34729. doi: 10.1074/jbc.273.52.34724
Rosen, G. M., Tsai, P., Weaver, J., Porasuphatana, S., Roman, L. J., Starkov, A. A., et al. (2002). The role of tetrahydrobiopterin in the regulation of neuronal nitric-oxide synthase-generated superoxide. J. Biol. Chem. 277, 40275–40280. doi: 10.1074/jbc.M200853200
Russell, K. S., Haynes, M. P., Caulin-Glaser, T., Rosneck, J., Sessa, W. C., and Bender, J. R. (2000). Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells effects on calcium sensitivity and no release. J. Biol. Chem. 275, 5026–5030. doi: 10.1074/jbc.275.7.5026
Sánchez, A., Contreras, C., Martínez, M. P., Climent, B., Benedito, S., García-Sacristán, A., et al. (2012). Role of Neural NO Synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese zucker rats. PLOS ONE 7:e36027. doi: 10.1371/journal.pone.0036027
Silva, G. C., Silva, J. F., Diniz, T. F., Lemos, V. S., and Cortes, S. F. (2016). Endothelial dysfunction in DOCA-salt-hypertensive mice: role of neuronal nitric oxide synthase-derived hydrogen peroxide. Clin. Sci. Lond. Engl. 130, 895–906. doi: 10.1042/cs20160062
Trabold, F., Pons, S., Hagege, A. A., Bloch-Faure, M., Alhenc-Gelas, F., Giudicelli, J.-F., et al. (2002). Cardiovascular phenotypes of kinin B2 receptor– and tissue kallikrein–deficient mice. Hypertension 40, 90–95. doi: 10.1161/01.HYP.0000021747.43346.95
Tsutsui, M., Onoue, H., Iida, Y., Smith, L., O'Brien, T., and Katusic, Z. S. (2000). B1 and B2 bradykinin receptors on adventitial fibroblasts of cerebral arteries are coupled to recombinant eNOS. Am. J. Physiol. Heart Circ. Physiol. 278, H367–H372. Available online at: http://ajpheart.physiology.org/content/278/2/H367
Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., Hogg, N., Masters, B. S. S., Karoui, H., et al. (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U.S.A. 95, 9220–9225. doi: 10.1073/pnas.95.16.9220
Weaver, J., Porasuphatana, S., Tsai, P., Pou, S., Roman, L. J., and Rosen, G. M. (2005). A comparative study of neuronal and inducible nitric oxide synthases: generation of nitric oxide, superoxide, and hydrogen peroxide. Biochim. Biophys. Acta 1726, 302–308. doi: 10.1016/j.bbagen.2005.08.012
Willars, G. B., Müller-Esterl, W., and Nahorski, S. R. (1999). Receptor phosphorylation does not mediate cross talk between muscarinic M3 and bradykinin B2 receptors. Am. J. Physiol. Cell Physiol. 277, C859–C869.
Keywords: kinin receptors, nitric oxide synthases, reactive oxygen species, nitric oxide, vasorelaxation, endothelial dysfunction
Citation: Mesquita TRR, Campos-Mota GP, Lemos VS, Cruz JS, de Jesus ICG, Camargo EA, Pesquero JL, Pesquero JB, Capettini LDSA and Lauton-Santos S (2017) Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase. Front. Physiol. 8:228. doi: 10.3389/fphys.2017.00228
Received: 09 January 2017; Accepted: 31 March 2017;
Published: 28 April 2017.
Edited by:Ovidiu Constantin Baltatu, Anhembi Morumbi University, Brazil
Reviewed by:Coen Maas, University Medical Center Utrecht, Netherlands
Mariarosaria Santillo, University of Naples Federico II, Italy
Copyright © 2017 Mesquita, Campos-Mota, Lemos, Cruz, de Jesus, Camargo, Pesquero, Pesquero, Capettini and Lauton-Santos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
†These authors have contributed equally to this work.